8-K current report · filed Nov 12, 2026

Corteva (CTVA) 8-K Current Report: November 12, 2026

Item 2.02Item EX-99.1Item EX-99.3Item EX-99.2CTVA overview

Short answer

Corteva (CTVA) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.3 (Exhibit EX-99.3), Item EX-99.2 (Exhibit EX-99.2). Corteva announced consolidated results for the quarter ended September 30, 2026.

Corteva 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Corteva announced consolidated results for the quarter ended September 30, 2026
  • Press release and financial statement schedules filed as Exhibits 99.1 and 99.2, providing the substantive financial details

Item EX-99.1 · Exhibit EX-99.1

  • Q3 net sales $1.591B, down 9%, with adjusted Operating EBITDA $222M, down 17%, signaling substantial market pressure
  • YTD adjusted Operating EPS $0.76, up 49%, despite GAAP EPS $0.16, down 68%, highlighting significant non-GAAP adjustments
  • Brazil weakness drove Latin America organic sales down 31% in Q3, with volume down 24% amid inventory and farmer liquidity constraints
  • FY 2026 guidance reduced to adjusted Operating EBITDA $1.1B-$1.125B and adjusted Operating EPS $0.76-$0.80
  • Board authorized Corteva’s first common dividend following the Seed business spin, creating a new shareholder-return mechanism

Item EX-99.2 · Exhibit EX-99.2

  • Pro forma Q3 net sales $1,591M, down 9% year over year, with organic sales down 9% and Latin America down 31%
  • Q3 adjusted operating EBITDA $222M, margin 14.0%, versus $268M and 15.4% in 2025
  • Q3 pro forma net loss $56M, or $(0.08) per share, versus $58M profit and $0.09 per share
  • Nine-month adjusted operating EBITDA $943M, up from $937M, while adjusted EPS improved to $0.76 from $0.51
  • September 30 pro forma balance sheet: $1,798M cash, $1,004M total debt, and $12,120M total equity

Item EX-99.3 · Exhibit EX-99.3

  • Spin-off completed October 1, 2026, creating New Corteva as a standalone Crop Protection company and Vylor as the Seed business
  • Pro forma debt reduced by $2.211 billion, including $1.439 billion of exchanged notes and $783 million of short-term borrowings repaid
  • Standalone balance sheet shows $1.798 billion cash, $944 million long-term debt and $11.881 billion New Corteva equity
  • Nine-month 2026 pro forma sales $5.357 billion and net income $105 million, versus $5.419 billion and $340 million in 2025
  • Autonomous-company adjustments reduced nine-month 2026 sales by $179 million and income by $114 million, highlighting separation-related earnings pressure

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Corteva 8-K filings

Get the next CTVA 8-K as it lands

Follow CTVA for push alerts, or ask the research agent what this filing means.